The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Gold nanoparticles in delivery applications☆
GHOSH, P., HAN, G., DE, M., KIM, C., & ROTELLO, V (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.016 · Cited by 2,694
Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity
Connor, E. E., Mwamuka, J., Gole, A., Murphy, C. J., & Wyatt, M. D. (2005) · Small · doi:10.1002/smll.200400093 · Cited by 2,406
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Kratz, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.010 · Cited by 2,151
Polysaccharides-based nanoparticles as drug delivery systems
Liu, Z., Jiao, Y., Wang, Y., Zhou, C., & Zhang, Z. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.001 · Cited by 1,732
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Huang, X., Jain, P. K., El-Sayed, I. H., & El-Sayed, M. A. (2007) · Nanomedicine · doi:10.2217/17435889.2.5.681 · Cited by 1,503
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.003 · Cited by 1,478
Responsive polymers in controlled drug delivery
Bajpai, A. K., Shukla, S. K., Bhanu, S., & Kankane, S. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2008.07.005 · Cited by 1,391
Gold nanoparticles: a new X-ray contrast agent
Hainfeld, J. F., Slatkin, D. N., Focella, T. M., & Smilowitz, H. M. (2006) · The British Journal of Radiology · doi:10.1259/bjr/13169882 · Cited by 1,351
Formulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery
Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.047 · Cited by 1,273
Desai, N., Trieu, V., Yao, Z., Louie, L., Ci, S., Yang, A., Tao, C., De, T., Beals, B., Dykes, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1634 · Cited by 1,175
Nanotechnology and nanomaterials: Promises for improved tissue regeneration
Zhang, L., & Webster, T. J. (2009) · Nano Today · doi:10.1016/j.nantod.2008.10.014 · Cited by 1,143
Biological applications of quantum dots
Jamieson, T., Bakhshi, R., Petrova, D., Pocock, R., Imani, M., & Seifalian, A. M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.07.014 · Cited by 1,107
Self-citationNanoparticles for drug delivery: The need for precision in reporting particle size parameters
Gaumet, M., Vargas, A., Gurny, R., & Delie, F. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.001 · Cited by 1,081
Glutathione in Cancer Biology and Therapy
Estrela, J. M., Ortega, A., & Obrador, E. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500523878 · Cited by 1,041
Inorganic nanoparticles as carriers for efficient cellular delivery
Xu, Z. P., Zeng, Q. H., Lu, G. Q., & Yu, A. B. (2006) · Chemical Engineering Science · doi:10.1016/j.ces.2005.06.019 · Cited by 976
Multiple molecular mechanisms for multidrug resistance transporters
Higgins, C. F. (2007) · Nature · doi:10.1038/nature05630 · Cited by 860
Glutathione-Mediated Delivery and Release Using Monolayer Protected Nanoparticle Carriers
Hong, R., Han, G., Fernández, J. M., Kim, B.-J., Forbes, N. S., & Rotello, V. M. (2006) · Journal of the American Chemical Society · doi:10.1021/ja056726i · Cited by 817
Nanoparticles for drug delivery in cancer treatment
Haley, B., & Frenkel, E. (2008) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.015 · Cited by 791
Protein nanoparticles as drug carriers in clinical medicine
Hawkins, M. J., Soon-Shiong, P., & Desai, N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.044 · Cited by 779
The origins and evolution of “controlled” drug delivery systems
Hoffman, A. S. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.012 · Cited by 738
PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery
Chan, J. M., Zhang, L., Yuet, K. P., Liao, G., Rhee, J.-W., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.013 · Cited by 702
Galley, H. F., & Webster, N. R. (2004) · British Journal of Anaesthesia · doi:10.1093/bja/aeh163 · Cited by 697
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Danhier, F., Lecouturier, N., Vroman, B., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.086 · Cited by 616
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆
WONG, H., BENDAYAN, R., RAUTH, A., LI, Y., & WU, X. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.008 · Cited by 578
Zensi, A., Begley, D., Pontikis, C., Legros, C., Mihoreanu, L., Wagner, S., Büchel, C., von Briesen, H., & Kreuter, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.002 · Cited by 438
Kim, D.-H., & Martin, D. C. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.12.021 · Cited by 430
Manjunath, K., & Venkateswarlu, V. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.006 · Cited by 380
In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin–PLGA conjugates
Yoo, H. S., Lee, K. H., Oh, J. E., & Park, T. G. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00280-7 · Cited by 374
Hu, K., Li, J., Shen, Y., Lu, W., Gao, X., Zhang, Q., & Jiang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.016 · Cited by 354
Clinical toxicities of nanocarrier systems.
Vega-Villa, K. R., Takemoto, J. K., Yáñez, J. A., Remsberg, C. M., Forrest, M. L., & Davies, N. M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.007 · Cited by 325
Juillerat-Jeanneret, L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.09.005 · Cited by 314
Feng, S.-S., Mei, L., Anitha, P., Gan, C. W., & Zhou, W. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.045 · Cited by 306
Translocation and fate of multi-walled carbon nanotubes in vivo
Deng, X., Jia, G., Wang, H., Sun, H., Wang, X., Yang, S., Wang, T., & Liu, Y. (2007) · Carbon · doi:10.1016/j.carbon.2007.03.035 · Cited by 265
Solid lipid nanoparticles for pulmonary delivery of insulin
Liu, J., Gong, T., Fu, H., Wang, C., Wang, X., Chen, Q., Zhang, Q., He, Q., & Zhang, Z. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.008 · Cited by 248
Drug targeting with nano-sized carrier systems
Yokoyama, M. (2005) · Journal of Artificial Organs · doi:10.1007/s10047-005-0285-0 · Cited by 232
Ciprofloxacin-Protected Gold Nanoparticles
Tom, R. T., Suryanarayanan, V., Reddy, P. G., Baskaran, S., & Pradeep, T. (2004) · Langmuir · doi:10.1021/la0358567 · Cited by 231
Nagayama, S., Ogawara, K.-I., Fukuoka, Y., Higaki, K., & Kimura, T. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.036 · Cited by 225
Pandey, R., Zahoor, A., Sharma, S., & Khuller, G. K. (2003) · Tuberculosis · doi:10.1016/j.tube.2003.07.001 · Cited by 220
Inner ear drug delivery for auditory applications
Swan, E. E. L., Mescher, M. J., Sewell, W. F., Tao, S. L., & Borenstein, J. T. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.001 · Cited by 216
Lee, S. H., Bae, K. H., Kim, S. H., Lee, K. R., & Park, T. G. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.027 · Cited by 215
Gold Nanoparticles Enhance the Anti-Leukemia Action of a 6-Mercaptopurine Chemotherapeutic Agent
Podsiadlo, P., Sinani, V. A., Bahng, J. H., Kam, N. W. S., Lee, J., & Kotov, N. A. (2008) · Langmuir · doi:10.1021/la702782k · Cited by 213
Lu, W., Wan, J., She, Z., & Jiang, X. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.015 · Cited by 193
Yaghini, E., Seifalian, A. M., & MacRobert, A. J. (2009) · Nanomedicine · doi:10.2217/nnm.09.9 · Cited by 176
Self-citationIn vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors
Jain, A., & Jain, S. K. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.08.008 · Cited by 169
Serpe, L., Catalano, M. G., Cavalli, R., Ugazio, E., Bosco, O., Canaparo, R., Muntoni, E., Frairia, R., Gasco, M. R., Eandi, M., et al. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.026 · Cited by 165
Kinetics of gold nanoparticles in the human placenta
Myllynen, P. K., Loughran, M. J., Howard, C. V., Sormunen, R., Walsh, A. A., & Vähäkangas, K. H. (2008) · Reproductive Toxicology · doi:10.1016/j.reprotox.2008.06.008 · Cited by 158
Galactosylated fluorescent labeled micelles as a liver targeting drug carrier
Wu, D.-Q., Lu, B., Chang, C., Chen, C.-S., Wang, T., Zhang, Y.-Y., Cheng, S.-X., Jiang, X.-J., Zhang, X.-Z., & Zhuo, R.-X. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.11.027 · Cited by 158
Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells
Gryparis, E. C., Hatziapostolou, M., Papadimitriou, Ε., & Avgoustakis, K. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.12.017 · Cited by 139
Oh, S. K. W., Kim, B. J., Singh, N. P., Lai, H. C., & Sasaki, T. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.08.031 · Cited by 131
Lu, B., Xiong, S.-B., Yang, H., et al. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.01.001 · Cited by 120
Ogawara, K.-I., Un, K., Tanaka, K.-I., Higaki, K., & Kimura, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.008 · Cited by 101
Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages
Vyas, S. P., QURAISHI, S., Gupta, S., & Jaganathan, K. S. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.02.003 · Cited by 100
Factors affecting toxicity and efficacy of polymeric nanomedicines
Igarashi, E. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.02.007 · Cited by 90
Ogawara, K., Un, K., Minato, K., Tanaka, K.-I., Higaki, K., & Kimura, T. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.025 · Cited by 89
Qiu, L., Jing, N., & Jin, Y. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.010 · Cited by 87
Attenuation of Kindled Seizures by Intranasal Delivery of Neuropeptide-Loaded Nanoparticles
Kubek, M. J., Domb, A. J., & Veronesi, M. C. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.02.001 · Cited by 80
Inhalable liposomal formulation for vasoactive intestinal peptide
Hajos, F., Stark, B., Hensler, S., Prassl, R., & Mosgoeller, W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.046 · Cited by 64
Liposomal doxorubicin in combination with bortezomib for relapsed or refractory multiple myeloma.
Ning, Y. M., He, K., Dagher, R. N., et al. (2007) · PubMed · Cited by 64
Wei, X., Mo, Z., Li, B., & Jin-min, W. (2007) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2007.04.016 · Cited by 58
Moraes, C. M., de Matos, A. P., de Paula, E., Rosa, A. H., & Fraceto, L. F. (2009) · Materials Science and Engineering B · doi:10.1016/j.mseb.2009.06.011 · Cited by 46
Tumor targeting of vincristine by mBAFF-modified PEG liposomes in B lymphoma cells
Zhang, L., Gao, H., Chen, L., Wu, B., Zheng, Y., Liao, R., Jiang, Y., & He, F. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.024 · Cited by 25
Ju‐Nam, Y., Allen, D. W., Gardiner, P. H. E., Light, M. E., Hursthouse, M. B., & Bricklebank, N. (2007) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2007.07.038 · Cited by 11
Cited by
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288
Metadata
- Authors
- Malam, Y., Loizidou, M., & Seifalian, A. M.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 30
- Issue
- 11
- Pages
- 592-599
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W1967637067
- Cited by
- 1,318
- References
- 64
- FWCI
- 22.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.